Vector-borne diseases (VBDs) represent a significant public health challenge in India, with millions affected annually. These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, pose a significant burden on the healthcare system.
India is disproportionately affected by VBDs, with diseases like malaria, dengue, and chikungunya being widespread. The World Health Organization reports that India accounts for 4% of global malaria cases. Dengue, too, is rampant, with over 100,000 cases reported annually.
Managing VBDs in India is a complex task, given the diverse geography and climate, which provide ideal breeding grounds for vectors. Additionally, socio-economic factors, such as population density and sanitation standards, exacerbate the situation.
Healthcare professionals play a pivotal role in combating VBDs. Their responsibilities include early detection, timely treatment, and educating the public about preventive measures. However, the lack of resources and training often hampers their efforts.
There is an urgent need for a comprehensive approach to tackle VBDs. This includes strengthening surveillance systems, improving diagnostic facilities, and enhancing vector control measures. Healthcare professionals must also be equipped with the necessary skills and resources to effectively manage these diseases.
Vector-borne diseases continue to pose a significant health risk in India. The onus is on healthcare professionals to lead the fight against these diseases. With concerted efforts and effective strategies, it is possible to reduce the burden of VBDs and improve public health outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation